Literature DB >> 32396847

Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.

Jean-Christophe Beltra1, Sasikanth Manne2, Mohamed S Abdel-Hakeem3, Makoto Kurachi4, Josephine R Giles1, Zeyu Chen2, Valentina Casella5, Shin Foong Ngiow1, Omar Khan6, Yinghui Jane Huang2, Patrick Yan6, Kito Nzingha2, Wei Xu7, Ravi K Amaravadi7, Xiaowei Xu8, Giorgos C Karakousis9, Tara C Mitchell7, Lynn M Schuchter7, Alexander C Huang10, E John Wherry11.   

Abstract

CD8+ T cell exhaustion is a major barrier to current anti-cancer immunotherapies. Despite this, the developmental biology of exhausted CD8+ T cells (Tex) remains poorly defined, restraining improvement of strategies aimed at "re-invigorating" Tex cells. Here, we defined a four-cell-stage developmental framework for Tex cells. Two TCF1+ progenitor subsets were identified, one tissue restricted and quiescent and one more blood accessible, that gradually lost TCF1 as it divided and converted to a third intermediate Tex subset. This intermediate subset re-engaged some effector biology and increased upon PD-L1 blockade but ultimately converted into a fourth, terminally exhausted subset. By using transcriptional and epigenetic analyses, we identified the control mechanisms underlying subset transitions and defined a key interplay between TCF1, T-bet, and Tox in the process. These data reveal a four-stage developmental hierarchy for Tex cells and define the molecular, transcriptional, and epigenetic mechanisms that could provide opportunities to improve cancer immunotherapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8; PD-1 blockade; T cell exhaustion lineage; T-bet; TCF1; Tox; cancer immunotherapy; chronic infection; epigenetics; exhaustion

Mesh:

Substances:

Year:  2020        PMID: 32396847     DOI: 10.1016/j.immuni.2020.04.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  141 in total

Review 1.  Navigating CAR-T cells through the solid-tumour microenvironment.

Authors:  Andrew J Hou; Laurence C Chen; Yvonne Y Chen
Journal:  Nat Rev Drug Discov       Date:  2021-05-10       Impact factor: 84.694

2.  CD8 T cells drive anorexia, dysbiosis, and blooms of a commensal with immunosuppressive potential after viral infection.

Authors:  Lara Labarta-Bajo; Anna Gramalla-Schmitz; Romana R Gerner; Katelynn R Kazane; Gregory Humphrey; Tara Schwartz; Karenina Sanders; Austin Swafford; Rob Knight; Manuela Raffatellu; Elina I Zúñiga
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 3.  T cell factor 1: A master regulator of the T cell response in disease.

Authors:  Giulia Escobar; Davide Mangani; Ana C Anderson
Journal:  Sci Immunol       Date:  2020-11-06

Review 4.  Organized immune cell interactions within tumors sustain a productive T-cell response.

Authors:  Maria A Cardenas; Nataliya Prokhnevska; Haydn T Kissick
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823

Review 5.  TCF1 in T cell immunity: a broadened frontier.

Authors:  Xudong Zhao; Qiang Shan; Hai-Hui Xue
Journal:  Nat Rev Immunol       Date:  2021-06-14       Impact factor: 53.106

Review 6.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

Review 7.  Emerging concepts in PD-1 checkpoint biology.

Authors:  Kristen E Pauken; James A Torchia; Apoorvi Chaudhri; Arlene H Sharpe; Gordon J Freeman
Journal:  Semin Immunol       Date:  2021-05-15       Impact factor: 11.130

8.  Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage.

Authors:  Jonathan B Johnnidis; Yuki Muroyama; Shin Foong Ngiow; Zeyu Chen; Sasikanth Manne; Zhangying Cai; Shufei Song; Jesse M Platt; Jason M Schenkel; Mohamed Abdel-Hakeem; Jean-Christophe Beltra; Allison R Greenplate; Mohammed-Alkhatim A Ali; Kito Nzingha; Josephine R Giles; Christelle Harly; John Attanasio; Kristen E Pauken; Bertram Bengsch; Michael A Paley; Vesselin T Tomov; Makoto Kurachi; Dario A A Vignali; Arlene H Sharpe; Steven L Reiner; Avinash Bhandoola; F Bradley Johnson; E John Wherry
Journal:  Sci Immunol       Date:  2021-01-15

Review 9.  Metabolic and epigenetic regulation of T-cell exhaustion.

Authors:  Fabien Franco; Alison Jaccard; Pedro Romero; Yi-Ru Yu; Ping-Chih Ho
Journal:  Nat Metab       Date:  2020-09-21

10.  Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.

Authors:  Shannon M Liudahl; Courtney B Betts; Shamilene Sivagnanam; Jonathan A Nowak; Brian M Wolpin; Lisa M Coussens; Vicente Morales-Oyarvide; Annacarolina da Silva; Chen Yuan; Samuel Hwang; Alison Grossblatt-Wait; Kenna R Leis; William Larson; Meghan B Lavoie; Padraic Robinson; Andressa Dias Costa; Sara A Väyrynen; Thomas E Clancy; Douglas A Rubinson; Jason Link; Dove Keith; Wesley Horton; Margaret A Tempero; Robert H Vonderheide; Elizabeth M Jaffee; Brett Sheppard; Jeremy Goecks; Rosalie C Sears; Byung S Park; Motomi Mori
Journal:  Cancer Discov       Date:  2021-03-16       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.